1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sulfapyridine in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sulfapyridine) | Trials (sulfapyridine) | Recent Studies (post-2010) (sulfapyridine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 487 | 30 | 77 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | sulfapyridine (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 0.276 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.276 | |
| Carbonic anhydrase 6 | Homo sapiens (human) | 0.276 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eliakim, R; Karmeli, F; Rachmilewitz, D; Razin, E | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulfapyridine
| Article | Year |
|---|---|
Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Topics: Adult; Aminosalicylic Acids; Calcimycin; Colitis, Ulcerative; Colon; Drug Combinations; Female; Glucosamine; Humans; Immunoglobulin E; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Prednisolone; Rectum; Sulfapyridine; Sulfasalazine | 1988 |